Arcera Life Sciences releases inaugural Sustainability Report
Abu Dhabi, UAE, December 18, 2025 – Arcera Life Sciences, a global life sciences company established by ADQ, an active sovereign investor with a focus on critical infrastructure and global supply chains, today announced the publication of its first Sustainability Report. The 2024 report marks a major milestone in Arcera’s journey as a global life sciences company and reflects its progress in integrating environmental, social, and governance (ESG) principles across all areas of its business.
"We are committed to operating responsibly - advancing sustainability, supporting our people, strengthening trust, and ensuring we make a positive impact on the communities we serve,” said Isabel Afonso, CEO of Arcera. “This inaugural report establishes a clear baseline for our ESG strategy and reflects the dedication of our teams across Arcera.”
The report sets forth Arcera’s collective commitment to achieving targets aligned with the four pillars of its ESG strategy:
- Climate Action: A commitment to achieving net-zero greenhouse gas emissions by 2050 through targeted energy-reduction initiatives and expanded use of renewable energy across Arcera sites.
- Access to Healthcare: Expanding access to high-quality medicines for patients in more than 120 countries, supported by a diverse workforce of over 6,000 employees.
- Responsible Value Chain: Strengthening supplier partnerships to promote responsible sourcing and sustainable practices throughout the value chain.
- People, Communities & Governance: Investing in employee wellbeing, workplace satisfaction, community engagement, and strong governance frameworks that reinforce ethics, integrity, and compliance.
The full Sustainability Report can be read here.
About Arcera Life Sciences
Arcera Life Sciences is a global life sciences company headquartered in Abu Dhabi, United Arab Emirates. Our purpose is to enable longer and healthier lives while creating sustainable growth. We develop, manufacture, and commercialize a broad range of innovative and proven medicines in key international markets. With a large footprint reaching patients in over 120 markets, and manufacturing and packaging facilities in eight countries, we offer more than 2,000 medicines across various therapeutic areas worldwide. Arcera was established by ADQ, an active sovereign investor with a focus on critical infrastructure and global supply chains, to realize Abu Dhabi's ambition as a global leader in innovative and sustainable healthcare. To learn more about Arcera, visit www.arceralifesciences.com.
Contact
Media Relations Arcera:
media@arceralifesciences.com